Cell therapies represent an exciting and complex new treatment paradigm, with the potential to treat an enormous range of indications, and in some cases offer the possibility of a cure with only a single treatment.
Dr. Beth Shaz honored as one of Crain's 2018 Notable Women in Healthcare
We are proud to congratulate Dr. Beth Shaz, Executive Vice President, Chief Medical and Scientific Officer of NYBC on being named one of Crain’s
Notable Women in Healthcare.
CCS offers a comprehensive menu of products and services to develop, improve, and implement scientific studies in the areas of regenerative medicine, cell therapies, transfusion medicine, and related scientific and medical endeavors.
